Literature DB >> 11837227

Interaction between smoking and the Sstl polymorphism of the apo C-III gene determines plasma lipid response to diet.

P Pérez-Martínez1, P Gómez, E Paz, C Marín, E Gavilán Moral, J López-Miranda, J M Ordovas, R A Fernandez de la Puebla, F Pérez-Jiménez.   

Abstract

BACKGROUND: It has recently been demonstrated that the lipid profile of smokers improves if they follow a Mediterranean diet. AIM: To establish whether the Sstl polymorphism of the apo C-III gene interacts with smoking and determines the lipid response to diet in healthy subjects. METHODS AND
RESULTS: Fifty-nine volunteers (18 smokers: 8 with the S1S1 genotype, and 10 with the S2 allele; 41 non-smokers: 29 with the S1S1 genotype and 12 with the S1S2 genotype) consecutively followed three different diets: a diet enriched in saturated fatty acids (SFA) (38% fat, 20% SFA) followed by a randomised, cross-over period during which they ate a diet enriched in carbohydrates (NCEP-1) (30% fat, 10% SFA, 55% carbohydrates) and a diet enriched in monounsaturated fatty acids (MUFA) (8% fat, 22% MUFA). Cholesterol, triacylglycerol, LDL-cholesterol (LDL-C) and HDL-cholesterol (HDL-C) levels were measured at the end of each dietary period. The smokers carrying the S1S1 genotype were not influenced by any of the diets, but the atherogenic ratio decreased in the carriers of the S2 allele when they changed from the diet rich in SFA to a diet rich in olive oil or carbohydrates (p < 0.039). No significant difference was observed when the non-smoking carriers of the S2 allele changed from one diet to another, but there was a decrease in the LDL-C/HDL-C ratio when the subjects with the S1S1 genotype changed from the saturated diet to either of the other diets (p < 0.001).
CONCLUSIONS: Smoking interacts with the apo CM polymorphism and determines the level of lipid response to dietary changes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11837227

Source DB:  PubMed          Journal:  Nutr Metab Cardiovasc Dis        ISSN: 0939-4753            Impact factor:   4.222


  5 in total

Review 1.  Genetics, the environment, and lipid abnormalities.

Authors:  Jose M Ordovas; And Haiqing Shen
Journal:  Curr Cardiol Rep       Date:  2002-11       Impact factor: 2.931

2.  Association of lipoprotein lipase and apolipoprotein C-III genes polymorphism with acute myocardial infarction in diabetic patients.

Authors:  Tarek A Abd El-Aziz; Rasha H Mohamed; Reem M Hashem
Journal:  Mol Cell Biochem       Date:  2011-04-17       Impact factor: 3.396

3.  Genetic variations at ABCG5/G8 genes modulate plasma lipids concentrations in patients with familial hypercholesterolemia.

Authors:  A Garcia-Rios; P Perez-Martinez; F Fuentes; P Mata; J Lopez-Miranda; R Alonso; F Rodriguez; A Garcia-Olid; J Ruano; J M Ordovas; F Perez-Jimenez
Journal:  Atherosclerosis       Date:  2010-01-22       Impact factor: 5.162

4.  Associations among race/ethnicity, ApoC-III genotypes, and lipids in HIV-1-infected individuals on antiretroviral therapy.

Authors:  Andrea S Foulkes; David A Wohl; Ian Frank; Elaine Puleo; Stephanie Restine; Megan L Wolfe; Michael P Dube; Pablo Tebas; Muredach P Reilly
Journal:  PLoS Med       Date:  2006-03       Impact factor: 11.069

Review 5.  Association between apolipoprotein C3 Sst I, T-455C, C-482T and C1100T polymorphisms and risk of coronary heart disease.

Authors:  Bin Lin; Yiwei Huang; Mingying Zhang; Jun Wang; Yihua Wu
Journal:  BMJ Open       Date:  2014-01-14       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.